Search

Your search keyword '"Montalescot, G."' showing total 1,440 results

Search Constraints

Start Over You searched for: Author "Montalescot, G." Remove constraint Author: "Montalescot, G."
1,440 results on '"Montalescot, G."'

Search Results

151. 201Left atrial appendage closure for stroke prevention in patients with atrial fibrillation: the difficult task of estimating the possible benefit in real life setting

152. A prospective cardiometabolism ApPRoach of mechanisms of coronary plaque rupture to apprehend patients at risk of recurrent events — The APPROACH registry

154. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization

155. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry

156. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study

157. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

158. [Expert consensus document on the use of antiplatelet agents]

159. 2013 ESC clinical practice guidelines on diagnosis and treatment of stable ischemic heart disease (Review) [Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable]

160. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction The ATLANTIC-H-24 Analysis

162. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

163. P2Y12 inhibitors

164. 2050Impact on clinical outcome of on-treatment platelet reactivity according to concordant platelet function tests: the multi-test platelet function study

165. 3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE

167. P5355Impact of evacetrapib on glyvemic control: results from the accelerate trial

168. P2771What is the current need for PCI and extra-corporal-life-support (ECLS) in patients referred to a tertiary center for out-of-hospital-cardiac-arrest?

170. Real life versus score-predicted mortality in patients presented to the Heart Team

171. High diagnostic performances of 82 Rubidium-PET for the detection of coronary artery disease as compared to 99 Tc-MIBI with CZT gamma cameras in a population of overweighed patients and women

172. Possible role of microvascular dysfunction in the weak association found between stress myocardial blood flow measured with 82 Rubidium-PET and FFR values measured during coronary angiography

173. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

174. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

175. Vorapaxar in the secondary prevention of atherothrombotic events

176. Determinants of high platelet reactivity in rapid metabolizers with acute coronary syndrome

177. Radial access in patients with acute coronary syndrome without persistent ST-segment elevation: Systematic review, collaborative meta-analysis, and meta-regression

178. Revascularization strategies in acute myocardial infarction: a meta-analysis

179. [Expert consensus document on the use of antiplatelet agents]

180. 2014 ESC/EACTS Guidelines on myocardial revascularization

181. 2014 ESC/EACTS Guidelines on myocardial revascularization

182. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes

183. Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease

184. The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation

185. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization

186. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

187. Exome sequencing of extreme clopidogrel response phenotypes identifiesB4GALT2as a determinant of on-treatment platelet reactivity

188. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

189. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes

190. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

191. Altered fibrin clot structure/function and FXIII Leu34 genetic variant in patients with premature coronary artery disease

192. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

194. Le séquençage du gène de la transthyrétine est un examen rentable et non invasif qui peut être demandé en première intention devant une cardiopathie présumée amyloïde sans argument biologique sérique pour une amylose AL ou AA

195. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events

197. Evaluation of infartct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO 8Facilitated Intervention With Enhanced Reperfusion Speed to Events-Angiographic )study

198. on behalf of the FINESSE angiographic sub-study investigators. Evaluation of Infarct Related Coronary Artery Patency and Microcirculatory Function after Facilitated Percutaneous Primary Coronary Angioplasty. The FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events Angiographic) Study

199. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study

Catalog

Books, media, physical & digital resources